We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
-1.07%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.41B
AUM Growth
+$209M
Cap. Flow
+$293M
Cap. Flow %
8.59%
Top 10 Hldgs %
18.79%
Holding
129
New
4
Increased
103
Reduced
21
Closed
1

Sector Composition

Rank Sector Weight
1 Industrials 22.5%
2 Financials 14.47%
3 Technology 14.45%
4 Healthcare 11.13%
5 Consumer Discretionary 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMCO icon
51
Columbus McKinnon
CMCO
$596M
$26.7M 0.78%
734,153
+11,865
+2% +$440K
CCRN
52
DELISTED
Cross Country Healthcare
CCRN
$26.5M 0.78%
2,573,122
+257,053
+11% +$2.53M
NUS icon
53
Nu Skin
NUS
$254M
$26.5M 0.78%
622,728
+120,202
+24% +$5.04M
MTSI icon
54
MACOM Technology Solutions
MTSI
$19B
$26.4M 0.77%
1,226,212
+257,787
+27% +$5.04M
STAG icon
55
STAG Industrial
STAG
$7.43B
$26.2M 0.77%
887,265
+111,953
+14% +$3.32M
CAMP
56
DELISTED
CalAmp Corp.
CAMP
$25.9M 0.76%
97,645
+12,738
+15% +$3.14M
FCN icon
57
FTI Consulting
FCN
$4.95B
$25.9M 0.76%
244,075
-9,201
-4% -$939K
QDEL icon
58
QuidelOrtho
QDEL
$1.13B
$25.5M 0.75%
416,082
+61,037
+17% +$3.67M
FLIR
59
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$25.5M 0.75%
484,346
-19,772
-4% -$1.01M
TCBI icon
60
Texas Capital Bancshares
TCBI
$4.29B
$24.6M 0.72%
450,498
+57,958
+15% +$3.3M
MD icon
61
Pediatrix Medical
MD
$2.17B
$24.2M 0.71%
1,070,217
+168,975
+19% +$3.85M
MODV
62
DELISTED
ModivCare
MODV
$23.5M 0.69%
395,389
+50,635
+15% +$2.88M
CAI
63
DELISTED
CAI International, Inc.
CAI
$23.1M 0.68%
1,061,100
+41,424
+4% +$914K
CWST icon
64
Casella Waste Systems
CWST
$5.69B
$22.9M 0.67%
533,040
-141,975
-21% -$6.15M
BKU icon
65
Bankunited
BKU
$3.33B
$22.3M 0.65%
663,670
+90,550
+16% +$2.96M
CNS icon
66
Cohen & Steers
CNS
$4.19B
$21.9M 0.64%
398,757
-35,152
-8% -$1.86M
CHEF icon
67
Chefs' Warehouse
CHEF
$4.58B
$21.8M 0.64%
540,222
-44,857
-8% -$1.68M
CUBI icon
68
Customers Bancorp
CUBI
$2.65B
$21.4M 0.63%
1,033,465
+143,270
+16% +$2.84M
OHI icon
69
Omega Healthcare
OHI
$15B
$21.4M 0.63%
512,544
+54,718
+12% +$2.13M
AEL
70
DELISTED
American Equity Investment Life Holding Company
AEL
$20.9M 0.61%
864,989
+111,522
+15% +$2.7M
ASC icon
71
Ardmore Shipping
ASC
$703M
$20.7M 0.61%
3,099,935
+411,399
+15% +$2.88M
SUPN icon
72
Supernus Pharmaceuticals
SUPN
$2.65B
$20.4M 0.6%
743,992
+639,961
+615% +$19M
IEX icon
73
IDEX
IEX
$17.3B
$20.2M 0.59%
123,317
+4,368
+4% +$725K
VBTX
74
DELISTED
Veritex Holdings
VBTX
$20M 0.59%
823,417
+103,143
+14% +$2.54M
WWW icon
75
Wolverine World Wide
WWW
$1.64B
$19.9M 0.58%
704,093
+94,183
+15% +$2.53M

Similar funds

Aristotle Capital Boston's Q3 2019 Portfolio in Review

As of Q3 2019, Aristotle Capital Boston held 129 positions worth $3.41B, up 6.5% from $3.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston deployed $293M of net new capital in Q3 2019, opening 4 new positions and adding to 103 existing holdings. Its largest new stake was Treehouse Foods: 358,099 shares worth $19.9M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was HEICO Corp Class A, an estimated $16.5M trimmed.

  • Aristotle Capital Boston's largest Q3 2019 buy was Treehouse Foods: 358,099 shares worth $19.9M.
  • Aristotle Capital Boston added most to Enviri in Q3 2019, an estimated $21.2M increase.
  • Aristotle Capital Boston's biggest Q3 2019 reduction was HEICO Corp Class A, cutting an estimated $16.5M.
  • Aristotle Capital Boston fully exited Electronics for Imaging in Q3 2019, selling an estimated $57.1M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $3.41B portfolio in Q3 2019.
  • Aristotle Capital Boston opened 4 new positions and closed 1 in Q3 2019.
  • Aristotle Capital Boston's portfolio value rose 6.5% quarter-over-quarter to $3.41B.

Based on Aristotle Capital Boston's 13F filing for Q3 2019, filed 14 Nov 2019.